Document Page: First | Prev | Next | All | Image | This Release | Search

File: 123096_sep96_decls7_0006.txt
Page: 0006
Total Pages: 11

Subject: PREVENTION AND TREATMENT OF NERVE AGENT POISONING               

Unit: VAR. BUMED  

Parent Organization: BUMED       

Box  ID: BX303902

Folder Title: PREVENTION AND TREATMENT OF NERVE AGENT POISONING                                               

Document Number:          1

Folder Seq  #:         14



                                                            UNCLASSIFIED
           FM..8-285/NAVMED P-5041/AFM 160-11

                                    NOTE                                   no effect on the nicotinic symptoms. If the casualty
                 Use the casualty's own antidote auto-in-                  has abs'orbed little or-no nerve agent. the adminis-
                 jectors when providing aid. Do not use                    tration of a single dose of 2 mg of atropine by any
                 your injectors on a casualty. If you do. you              route produces symptoms of mild atropinization
                 may not have antidote available when                      (tachycardia. dry mouth) in most individuals and
                 needed for self-aid.                                      repetition of this dose within I or 2 hours produces
                                                                           moderate symptoms of atropinization in almost all
           2-12. Effects of Atropine                                       individuals. In contrast. a casualty with moderate
                                                                           symptomsof nerve agent poisoning will not develop
           The effect of atropine adminisLratiom.Gn m",and                 symp@f a@gr-ni=fon-after administration of
           moderate cases of nerve agent poisoning may help                2 mg of atropine. A casualty with severe symptoms
           confirm the diagnosis. Atropine injection alleviates            of nerve agent poisoning may tolerate-indeed may
           most of the musearinic manifestations. It has little            require-considerably more than 4 mg of atropine
           effect on the central nervous system symptoms and               (as much as 50 mg in 24 hours).


                 -                           Section IV. TREATMENT IN THE FIELD
                                                (MEDICAL TREATMENT FACILITY)
e Nerve Agent                              (1) Mild symptoms should have been treated by
                 . Antidotes                                               administeringatleastone6OO-mgIM injectionof2
           Ifacasualtyisstillexperiencingsigns/symptomsof                  PAM Cl.
           nerve agent poison     'ing (para 2-5) after receiving               (2) Moderatesymptomsshould havebeen treat-
           self-aid, buddy aid, or treatment by the Combat                 ed by administering one or more 600-mg IM injec-
                                                                           tion of 2 PAM'CL.
           Lifesaver, aidman. or medical personnel in the
           field. additional injections of the nerve agent anti-                (3) Severe symptoms should have b6en treated
           dote(s) will b-                                                 by administering three 600-mg IM injections of 2
                           e administered at the field medical
                                                                           PAM Cl. Repeat the dose at least every-hotir if
           treatment facilit-y as follows:                                 resl5iration has not improved. Generally, no int
              a, Atropine.
                 (1) NIildsymplomsshould betreated by zidmin-              creased oxiriie benefit isobtained after3 injections
           istering2 mgof theatropineevery 15 minutes-until                of 2 PAM Cl..
           signs of atropinization (dry mouth and skin, with               2-14. Adminiitration of Follow-on Mod-
           cleared pulmonary secretions) arlf a&hievid.'Ma'n-                       icai Treatment
           tain atropinization until muscarinic signs dis-
                 a                                                         Thefollowingadditional medical treattnentfnay be
           @ppe r.
                 (2) Moderate symptoms should be treated by                admirristeredinacollectiveprotectivesheiteroran
stering 2 mg of the'atropine every 10 to 15               uncontaminated environxnent, depending on the
           minutes until atropinizatiorlis achieved. Maintain              needs.of.the patient. MWifi @'cw of, t@e- proce-
           a,@@ion byfnlecting2mgof,it?opine as6ften                       dures may be used in v-contamin@ted environment
           and long as needed.                                             'n s-piteof theadditional exposure that would occur.
                 C3) Severe symptoms should be treated by                  since the alternative of not performing these proce-
           administering 2 mg of atropine as frequently as                 dures would result in death.
           required urrtii atropinization is achieved. Maintain              a. Adminiitratio7? of Additional Atropine. For-
           atr7opiriization by injecting 2 mg of atropine every            patients who are in severe respiratory distress
           I 0 to 30 m i n utes as long as needed.                         whe n fou nd or are con-vu Is i ng, a I I th ree sets of t hei r
                                                                           Mark I auto-injectorsshould have been given intra-
                                    NOTE                                   muscularly in rapid succession. (Convulsions should
                 Smoking should     be prohibited until the                be treated with diazepam-, as described in c below.)
                 symptoms of nerve agent poisoning have..                  lirelief d@notoccb'r and bronchial secretions and
                 subsfd-ed.                                                salivation do not decrease, administer atropine as
             b. 2 PAM Cl. Specifically as an adjunct to stro-              often as needed, depending on the transient effects
           pine, 2 PAM Cl may be used to increase the effec-               of the atropine. In severe nervd agent poisoning, the
l             effectof each injectionof atropine may be transient.
           nerve agents. An important facetof the activity of 2            lastl:ng only 5 to 15 minutes. Therefore, these
           PAM Cl in such therapy is the reduction of the                  patientsmustbeobserved ascloselyaspossibleand
           timesduringwhichassistedventilation isrequired.                 atropinerepeatedatappropriateintervalstorelieve

           2-14
                                                                    UNCLASSIFIED

Document Page: First | Prev | Next | All | Image | This Release | Search


Document 11 f:/Week-44/BX303902/PREVENTION AND TREATMENT OF NERVE AGENT POISONING/prevention and treatment of nerve agent poisonin:1217960956196
Control Fields 17
File Room = sep96_declassified
File Cabinet = Week-44
Box ID = BX303902
Unit = VAR. BUMED
Parent Organization = BUMED
Folder Title = PREVENTION AND TREATMENT OF NERVE AGENT POISONING
Folder Seq # = 14
Subject = PREVENTION AND TREATMENT OF NERVE AGENT POISONIN
Document Seq # = 1
Document Date =
Scan Date =
Queued for Declassification = 01-JAN-1980
Short Term Referral = 01-JAN-1980
Long Term Referral = 01-JAN-1980
Permanent Referral = 01-JAN-1980
Non-Health Related Document = 01-JAN-1980
Declassified = 17-DEC-1996